A Trial of Micronutrients and Adverse Pregnancy Outcomes
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
The purpose of this study is to examine the efficacy of multivitamin supplementation on fetal loss, low birth weight and severe preterm birth in healthy (HIV negative) women.
Condition | Intervention | Phase |
---|---|---|
Pregnancy Premature Birth Infant, Low Birth Weight Pregnancy Outcomes |
Dietary Supplement: Multivitamins-vitamins B-complex, C, and E Dietary Supplement: Placebo |
Phase 3 |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Prevention |
Official Title: | A Trial of Micronutrients and Adverse Pregnancy Outcomes |
- Fetal loss, low birth weight and pre-term birth. [ Time Frame: Delivery ] [ Designated as safety issue: No ]
- Child morbidity and mortality; child growth [ Time Frame: 12 months postpartum ] [ Designated as safety issue: No ]
Enrollment: | 8468 |
Study Start Date: | August 2001 |
Study Completion Date: | July 2006 |
Primary Completion Date: | December 2004 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Active Comparator: Multivitamins
Multivitamins-vitamins B-complex, C, and E
|
Dietary Supplement: Multivitamins-vitamins B-complex, C, and E
One daily oral dose of 20 mg of B1, 20 mg of B2, 25 mg of B6, 100 mg of niacin, 50 mcg of B12, 500 mg of C, and 30 mg of vitamin E from randomization until delivery. Participants may continue taking this intervention until 18 months post-partum if they are re-randomized to it after delivery.
|
Placebo Comparator: Placebo
Placebo pill
|
Dietary Supplement: Placebo
One daily oral dose of a placebo pill taken from randomization until delivery. Participants may continue taking this intervention until 18 months post-partum if they are re-randomized to it after delivery.
|
Detailed Description:
Fetal loss, low birth weight and preterm birth are major public health problems worldwide, particularly in developing countries. Birth outcomes are also major predictors of child health and survival in infancy and beyond. The purpose of this study is to examine the efficacy of multivitamin supplementation on fetal loss, low birth weight and severe preterm birth in healthy (HIV negative) women. We also aim to determine whether the potentially protective effect of multivitamin supplements on the risks of low birth weight and preterm birth translate into a sustained reduction in infant mortality.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- HIV negative
- 12-26 weeks gestational age at screening visit
Publications:
Responsible Party: | Wafaie Fawzi, Harvard School of Public of Health |
ClinicalTrials.gov Identifier: | NCT00197548 History of Changes |
Other Study ID Numbers: | HD37701 |
Study First Received: | September 12, 2005 |
Last Updated: | November 9, 2010 |
Health Authority: | United States: Federal Government Tanzania: Ministry of Health |
Keywords provided by Harvard School of Public Health:
Women Pregnancy Outcomes Nutrition |
Vitamins Tanzania Maternal and Child Health Outcomes |
Additional relevant MeSH terms:
Birth Weight Premature Birth Body Weight Signs and Symptoms Obstetric Labor, Premature Obstetric Labor Complications Pregnancy Complications Vitamin B Complex Folic Acid |
Micronutrients Vitamins Trace Elements Growth Substances Physiological Effects of Drugs Pharmacologic Actions Hematinics Hematologic Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on October 16, 2012